Nanotechnology-based drug delivery systems are transforming pharmaceutical treatments by enabling targeted therapy with reduced side effects. These innovative systems can deliver medications directly to affected tissues while bypassing healthy cells.

Our latest research focuses on biodegradable nanoparticles that release medication in response to specific biological triggers. This approach has shown promising results in clinical trials for cancer treatment, with a 40% reduction in systemic toxicity compared to conventional chemotherapy.